Key facts
- It has raised $28.1M; the latest was Later Stage VC ($14.4M) in Feb 2026.
- Notable investors include Shenzhen Capital Group, CAS Star, Beijing State-owned Capital Operation and Management, China Capital Management, Shenzhen Guozhong Venture Capital Management — 20 tracked in total.
- Status: Privately Held (backing).
Investors
20+- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Transcend Vivoscope
- ·The full record, as it builds
Funding rounds
No funding rounds for Transcend Vivoscope are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Transcend Vivoscope
Manufacturer of high-end biomedical imaging equipment designed to enable in vivo microscopic visualisation of neural and cellular activity. The company offers miniaturised multiphoton microscopes, specialised optical components, and endoscopic imaging systems, enabling neuroscience researchers, clinical clinicians, and pharmaceutical developers to conduct deep-tissue imaging with high spatial and temporal resolution and advance biological research and medical diagnostics.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2016
- Employees
- 100
- Website
- tv-scope.com/
- Ownership
- Privately Held (backing)
Transcend Vivoscope doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Transcend Vivoscope shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Transcend Vivoscope in its N-PORT filings yet. We sweep new filings monthly.